Compared with adherent cells, tumor sphere cells exhibited higher CD44 expression but showed no difference in NFIB expression (Figure S3E), suggesting that miR-302a suppressed the CSC-like phenotype by targeting CD44 but not NFIB. The gene discussed is NFIB; the disease is neoplasm.